SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 162 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 25 | -97.5% | 0.00% | -100.0% |
| Q4 2015 | $39,000 | +21.9% | 1,000 | 0.0% | 0.02% | +11.1% |
| Q3 2015 | $32,000 | +6.7% | 1,000 | 0.0% | 0.02% | +5.9% |
| Q2 2015 | $30,000 | +11.1% | 1,000 | -50.0% | 0.02% | +112.5% |
| Q1 2015 | $27,000 | +92.9% | 2,000 | +100.0% | 0.01% | 0.0% |
| Q4 2014 | $14,000 | -33.3% | 1,000 | 0.0% | 0.01% | -38.5% |
| Q3 2014 | $21,000 | -30.0% | 1,000 | 0.0% | 0.01% | -27.8% |
| Q2 2014 | $30,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |